Published in FEMS Microbiol Rev on June 06, 2011
Fungal biofilm resistance. Int J Microbiol (2012) 1.73
Biofilms: An Underappreciated Mechanism of Treatment Failure and Recurrence in Vaginal Infections. Clin Infect Dis (2015) 1.44
Candida glabrata: a review of its features and resistance. Eur J Clin Microbiol Infect Dis (2013) 1.36
Emerging and emerged pathogenic Candida species: beyond the Candida albicans paradigm. PLoS Pathog (2013) 1.26
Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis. Microbiome (2014) 1.05
Non-albicans Candida Infection: An Emerging Threat. Interdiscip Perspect Infect Dis (2014) 0.92
Role of matrix β-1,3 glucan in antifungal resistance of non-albicans Candida biofilms. Antimicrob Agents Chemother (2013) 0.91
Sphingolipid biosynthetic pathway genes FEN1 and SUR4 modulate amphotericin B resistance. Antimicrob Agents Chemother (2014) 0.88
Yeast: a simple model system to study complex phenomena of aneuploidy. FEMS Microbiol Rev (2013) 0.88
Mortality in patients with early- or late-onset candidaemia. J Antimicrob Chemother (2012) 0.87
The Candida pathogenic species complex. Cold Spring Harb Perspect Med (2014) 0.86
ER stress response mechanisms in the pathogenic yeast Candida glabrata and their roles in virulence. Virulence (2013) 0.85
Lectin-Glycan Interaction Network-Based Identification of Host Receptors of Microbial Pathogenic Adhesins. MBio (2016) 0.84
In vitro and in vivo activity of a novel antifungal small molecule against Candida infections. PLoS One (2014) 0.84
Urinary tract infections and Candida albicans. Cent European J Urol (2015) 0.82
Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis. Adv Biomed Res (2015) 0.82
Resistant pathogens, fungi, and viruses. Surg Clin North Am (2014) 0.82
The Black Yeast Exophiala dermatitidis and Other Selected Opportunistic Human Fungal Pathogens Spread from Dishwashers to Kitchens. PLoS One (2016) 0.82
Adhesion, biofilm formation, cell surface hydrophobicity, and antifungal planktonic susceptibility: relationship among Candida spp. Front Microbiol (2015) 0.81
First description of Candida nivariensis in Brazil: antifungal susceptibility profile and potential virulence attributes. Mem Inst Oswaldo Cruz (2016) 0.81
Human endothelial cells internalize Candida parapsilosis via N-WASP-mediated endocytosis. Infect Immun (2013) 0.80
Antifungal Activity of 14-Helical β-Peptides against Planktonic Cells and Biofilms of Candida Species. Pharmaceuticals (Basel) (2015) 0.80
Targeted gene disruption in Candida parapsilosis demonstrates a role for CPAR2_404800 in adhesion to a biotic surface and in a murine model of ascending urinary tract infection. Virulence (2015) 0.80
Overexpression of Both ERG11 and ABC2 Genes Might Be Responsible for Itraconazole Resistance in Clinical Isolates of Candida krusei. PLoS One (2015) 0.79
Candida growth in urine cultures: a contemporary analysis of species and antifungal susceptibility profiles. QJM (2015) 0.79
Identification of genomic binding sites for Candida glabrata Pdr1 transcription factor in wild-type and ρ0 cells. Antimicrob Agents Chemother (2014) 0.79
Influence of culture media on biofilm formation by Candida species and response of sessile cells to antifungals and oxidative stress. Biomed Res Int (2015) 0.79
Inhibitory Effect of Sophorolipid on Candida albicans Biofilm Formation and Hyphal Growth. Sci Rep (2016) 0.79
Investigation of an unrecognized large-scale outbreak of Candida parapsilosis sensu stricto fungaemia in a tertiary-care hospital in China. Sci Rep (2016) 0.78
In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen. Jundishapur J Microbiol (2016) 0.78
Establishment of an in vitro system to study intracellular behavior of Candida glabrata in human THP-1 macrophages. J Vis Exp (2013) 0.78
Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study. Antimicrob Agents Chemother (2015) 0.78
Hemolytic factor production by clinical isolates of Candida species. Curr Microbiol (2013) 0.78
Alginate oligosaccharides inhibit fungal cell growth and potentiate the activity of antifungals against Candida and Aspergillus spp. PLoS One (2014) 0.78
Persea americana Glycolic Extract: In Vitro Study of Antimicrobial Activity against Candida albicans Biofilm and Cytotoxicity Evaluation. ScientificWorldJournal (2015) 0.78
Essential Oil of Cymbopogon nardus (L.) Rendle: A Strategy to Combat Fungal Infections Caused by Candida Species. Int J Mol Sci (2016) 0.77
The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study. BMC Infect Dis (2014) 0.77
Distinct Expression Levels of ALS, LIP, and SAP Genes in Candida tropicalis with Diverse Virulent Activities. Front Microbiol (2016) 0.77
Opportunistic fungal pathogen Candida glabrata circulates between humans and yellow-legged gulls. Sci Rep (2016) 0.76
Potential Antifungal Targets against a Candida Biofilm Based on an Enzyme in the Arachidonic Acid Cascade-A Review. Front Microbiol (2016) 0.76
Generational distribution of a Candida glabrata population: Resilient old cells prevail, while younger cells dominate in the vulnerable host. PLoS Pathog (2017) 0.76
Activity of fluconazole and its Cu(II) complex towards Candida species. Med Chem Res (2014) 0.75
Thionin-like peptide from Capsicum annuum fruits: mechanism of action and synergism with fluconazole against Candida species. BMC Microbiol (2016) 0.75
Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites. PLoS One (2016) 0.75
Biosynthesis of micro- and nanocrystals of Pb (II), Hg (II) and Cd (II) sulfides in four Candida species: a comparative study of in vivo and in vitro approaches. Microb Biotechnol (2017) 0.75
Candida species Rewired Hyphae Developmental Programs for Chlamydospore Formation. Front Microbiol (2016) 0.75
Phenolic composition and medicinal usage of Psidium guajava Linn.: Antifungal activity or inhibition of virulence? Saudi J Biol Sci (2015) 0.75
Medical Device-Associated Candida Infections in a Rural Tertiary Care Teaching Hospital of India. Interdiscip Perspect Infect Dis (2016) 0.75
Rapid detection of Candida species in bronchoalveolar lavage fluid from patients with pulmonary symptoms. Braz J Microbiol (2016) 0.75
Essential Oils, Silver Nanoparticles and Propolis as Alternative Agents Against Fluconazole Resistant Candida albicans, Candida glabrata and Candida krusei Clinical Isolates. Indian J Microbiol (2014) 0.75
Antifungal Susceptibility Patterns of Candida Species Recovered from Endotracheal Tube in an Intensive Care Unit. Adv Med (2016) 0.75
Synthesis and Evaluation of Biological Activity of Antimicrobial - Pro-Proliferative Peptide Conjugates. PLoS One (2015) 0.75
Multilocus sequence analyses reveal extensive diversity and multiple origins of fluconazole resistance in Candida tropicalis from tropical China. Sci Rep (2017) 0.75
Candida glabrata Esophagitis: Are We Seeing the Emergence of a New Azole-Resistant Pathogen? Int J Microbiol (2014) 0.75
Candida tropicalis as a Predominant Isolate from Clinical Specimens and its Antifungal Susceptibility Pattern in a Tertiary Care Hospital in Southern India. J Clin Diagn Res (2015) 0.75
Antifungal Susceptibility in Serum and Virulence Determinants of Candida Bloodstream Isolates from Hong Kong. Front Microbiol (2016) 0.75
Evaluation of Polymorphic Locus Sequence Typing for Candida glabrata Epidemiology. J Clin Microbiol (2016) 0.75
Hyperspectral fluorescence microscopy detects autofluorescent factors that can be exploited as a diagnostic method for Candida species differentiation. J Biomed Opt (2017) 0.75
Changes in the hemolytic activity of Candida species by common electrolytes. BMC Microbiol (2015) 0.75
Evaluation of Virulence Factors In vitro, Resistance to Osmotic Stress and Antifungal Susceptibility of Candida tropicalis Isolated from the Coastal Environment of Northeast Brazil. Front Microbiol (2016) 0.75
Pseudohyphae formation in Candida glabrata due to CO2 exposure. Curr Med Mycol (2016) 0.75
Ag(I) camphorimine complexes with antimicrobial activity towards clinically important bacteria and species of the Candida genus. PLoS One (2017) 0.75
Hyphal wall protein 1 gene: A potential marker for the identification of different Candida species and phylogenetic analysis. Curr Med Mycol (2016) 0.75
On the mechanism of Candida tropicalis biofilm reduction by the combined action of naturally-occurring anthraquinones and blue light. PLoS One (2017) 0.75
Multilocus microsatellite analysis of European and African Candida glabrata isolates. Eur J Clin Microbiol Infect Dis (2016) 0.75
Repeated applications of photodynamic therapy on Candida glabrata biofilms formed in acrylic resin polymerized. Lasers Med Sci (2017) 0.75
Relationship between the Antifungal Susceptibility Profile and the Production of Virulence-Related Hydrolytic Enzymes in Brazilian Clinical Strains of Candida glabrata. Mediators Inflamm (2017) 0.75
Biosurfactants: potential applications in medicine. J Antimicrob Chemother (2006) 2.02
Microbiology of the skin and the role of biofilms in infection. Int Wound J (2011) 1.92
The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Hum Mol Genet (2010) 1.73
The phage therapy paradigm: prêt-à-porter or sur-mesure? Pharm Res (2010) 1.73
Once-daily atomoxetine for adult attention-deficit/hyperactivity disorder: a 6-month, double-blind trial. J Clin Psychopharmacol (2009) 1.70
Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid fluorescent in situ hybridization (PNA FISH). Microbiology (2009) 1.47
A review of the scientific evidence for biofilms in wounds. Wound Repair Regen (2012) 1.42
Isolation and characterization of a T7-like lytic phage for Pseudomonas fluorescens. BMC Biotechnol (2008) 1.38
Quantitative analysis of adhesion and biofilm formation on hydrophilic and hydrophobic surfaces of clinical isolates of Staphylococcus epidermidis. Res Microbiol (2005) 1.38
Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol (2009) 1.37
Molecular basis for preferential protective efficacy of antibodies directed to the poorly acetylated form of staphylococcal poly-N-acetyl-beta-(1-6)-glucosamine. Infect Immun (2007) 1.35
Complete Genome Sequence of the Broad-Host-Range Paenibacillus larvae Phage phiIBB_Pl23. Genome Announc (2013) 1.35
Comparative assessment of antibiotic susceptibility of coagulase-negative staphylococci in biofilm versus planktonic culture as assessed by bacterial enumeration or rapid XTT colorimetry. J Antimicrob Chemother (2005) 1.33
Presence of extracellular DNA in the Candida albicans biofilm matrix and its contribution to biofilms. Mycopathologia (2009) 1.31
Molecular aspects and comparative genomics of bacteriophage endolysins. J Virol (2013) 1.25
The in vivo efficacy of two administration routes of a phage cocktail to reduce numbers of Campylobacter coli and Campylobacter jejuni in chickens. BMC Microbiol (2010) 1.19
Candida biofilms and oral candidosis: treatment and prevention. Periodontol 2000 (2011) 1.18
Addition of DNase improves the in vitro activity of antifungal drugs against Candida albicans biofilms. Mycoses (2011) 1.18
Morphogenesis control in Candida albicans and Candida dubliniensis through signaling molecules produced by planktonic and biofilm cells. Eukaryot Cell (2007) 1.17
Adherence and biofilm formation of non-Candida albicans Candida species. Trends Microbiol (2011) 1.17
Genomic and proteomic characterization of the broad-host-range Salmonella phage PVP-SE1: creation of a new phage genus. J Virol (2011) 1.17
Antimicrobial tolerance and the significance of persister cells in recalcitrant chronic wound biofilms. Wound Repair Regen (2011) 1.17
Physicochemical and functional characterization of a biosurfactant produced by Lactococcus lactis 53. Colloids Surf B Biointerfaces (2006) 1.16
Bacteriophage Phi S1 infection of Pseudomonas fluorescens planktonic cells versus biofilms. Biofouling (2004) 1.11
Detection of Candida in concentrated oral rinse cultures by real-time PCR. J Clin Microbiol (2004) 1.11
Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immun (2006) 1.10
Mechanisms of augmented growth of Pseudomonas aeruginosa mediated by Candida albicans. Crit Care Med (2014) 1.09
Biosurfactant from Lactococcus lactis 53 inhibits microbial adhesion on silicone rubber. Appl Microbiol Biotechnol (2004) 1.06
Effects of growth in the presence of subinhibitory concentrations of dicloxacillin on Staphylococcus epidermidis and Staphylococcus haemolyticus biofilms. Appl Environ Microbiol (2005) 1.05
Atomoxetine for the treatment of attention-deficit/hyperactivity disorder and oppositional defiant disorder. Pediatrics (2008) 1.05
Detection of cfxA and cfxA2, the beta-lactamase genes of Prevotella spp., in clinical samples from dentoalveolar infection by real-time PCR. J Clin Microbiol (2006) 1.04
Pseudomonas fluorescens biofilms subjected to phage phiIBB-PF7A. BMC Biotechnol (2008) 1.04
Isolation and partial characterization of a biosurfactant produced by Streptococcus thermophilus A. Colloids Surf B Biointerfaces (2006) 1.03
The use of antibiotics to improve phage detection and enumeration by the double-layer agar technique. BMC Microbiol (2009) 1.02
Corrosion behaviour of titanium in the presence of Streptococcus mutans. J Dent (2013) 1.01
Guidelines to cell engineering for monoclonal antibody production. Eur J Pharm Biopharm (2009) 1.01
Adhesion of Pseudomonas aeruginosa and Staphylococcus epidermidis to silicone-hydrogel contact lenses. Optom Vis Sci (2005) 1.01
Chondroitin product selection for the glucosamine/chondroitin arthritis intervention trial. J Am Pharm Assoc (2003) (2006) 1.00
Characterization of modular bacteriophage endolysins from Myoviridae phages OBP, 201φ2-1 and PVP-SE1. PLoS One (2012) 1.00
Lipopolysaccharide-induced M2 to M1 macrophage transformation for IL-12p70 production is blocked by Candida albicans mediated up-regulation of EBI3 expression. PLoS One (2013) 1.00
A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis. PLoS One (2010) 1.00
Comparative evaluation of coagulase-negative staphylococci (CoNS) adherence to acrylic by a static method and a parallel-plate flow dynamic method. Res Microbiol (2004) 0.99
The effect of hydrodynamic conditions on the phenotype of Pseudomonas fluorescens biofilms. Biofouling (2007) 0.99
Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study. J Atten Disord (2008) 0.98
Biofilms and bacterial imbalances in chronic wounds: anti-Koch. Int Wound J (2010) 0.96
Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients. Mycopathologia (2009) 0.95
The relationship between inhibition of bacterial adhesion to a solid surface by sub-MICs of antibiotics and subsequent development of a biofilm. Res Microbiol (2005) 0.95
An in vitro model of chronic wound biofilms to test wound dressings and assess antimicrobial susceptibilities. J Antimicrob Chemother (2010) 0.94
Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. Aust N Z J Psychiatry (2007) 0.94
SYBR green as a fluorescent probe to evaluate the biofilm physiological state of Staphylococcus epidermidis, using flow cytometry. Can J Microbiol (2011) 0.94
A suggested classification for two groups of Campylobacter myoviruses. Arch Virol (2013) 0.94
Pseudomonas fluorescens infection by bacteriophage PhiS1: the influence of temperature, host growth phase and media. FEMS Microbiol Lett (2004) 0.94
Cyclodextrins as encapsulation agents for plant bioactive compounds. Carbohydr Polym (2013) 0.93
Adhesion to and viability of Listeria monocytogenes on food contact surfaces. J Food Prot (2008) 0.93
Silicone colonization by non-Candida albicans Candida species in the presence of urine. J Med Microbiol (2010) 0.93
Use of newly isolated phages for control of Pseudomonas aeruginosa PAO1 and ATCC 10145 biofilms. Res Microbiol (2011) 0.92
Glycosylation: impact, control and improvement during therapeutic protein production. Crit Rev Biotechnol (2013) 0.92
The influence of surface treatment on hydrophobicity, protein adsorption and microbial colonisation of silicone hydrogel contact lenses. Cont Lens Anterior Eye (2007) 0.92
The genome and proteome of a Campylobacter coli bacteriophage vB_CcoM-IBB_35 reveal unusual features. Virol J (2012) 0.92
The role of extracellular polymers on Staphylococcus epidermidis biofilm biomass and metabolic activity. J Basic Microbiol (2009) 0.92
Molecular characterization of clinical and environmental isolates of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis from a teaching hospital in Wales. J Med Microbiol (2003) 0.92
Phage control of dual species biofilms of Pseudomonas fluorescens and Staphylococcus lentus. Biofouling (2010) 0.91
Role of bacterial lipopolysaccharide in enhancing host immune response to Candida albicans. Clin Dev Immunol (2013) 0.91
Candida glabrata and Candida albicans co-infection of an in vitro oral epithelium. J Oral Pathol Med (2010) 0.91
Influence of biosurfactants from probiotic bacteria on formation of biofilms on voice prostheses. Appl Environ Microbiol (2004) 0.91
In vitro activity of daptomycin, linezolid and rifampicin on Staphylococcus epidermidis biofilms. Curr Microbiol (2011) 0.91
Effect of farnesol on planktonic and biofilm cells of Staphylococcus epidermidis. Curr Microbiol (2009) 0.91
Staphylococcus epidermidis biofilms with higher proportions of dormant bacteria induce a lower activation of murine macrophages. J Med Microbiol (2011) 0.91